Target intelligence / Profile preview

Membrane transporter protein

Molecular classification
Transporter, Channel (for transporters forming pores), Carrier, ATP-binding cassette transporter (ABC transporter), Solute carrier (SLC), P-type ATPase
01

Overview

Membrane transporter proteins" is a broad, non-canonical term referring to a large and diverse family of integral membrane proteins that enable the movement of ions, small molecules, and sometimes large molecules across cell membranes[4][1][10]. These include channels (form aqueous pores) and carriers/transporters (undergo conformational changes to move substrates), with major superfamilies like the ATP-binding cassette (ABC) transporters, solute carrier (SLC) family, and P-type ATPases[10][7][4]. Transporters play a central role in physiology, drug pharmacokinetics, nutrition, and disease—being responsible for nutrient absorption, toxin/drug efflux, maintaining cellular homeostasis, and are implicated in the pathology and drug resistance seen in cancer, neurological, and metabolic diseases[2][3][9]. The term "multiple membrane transporter proteins" is not a specific canonical target, but refers to this whole class, and needs to be clarified or replaced with individual transporter names (e.g., P-glycoprotein, SLC6A4, ABCC1) for precise scientific or therapeutic context[4][7][10].

Other names
Transporter proteinChannel protein (for channels)Carrier proteinPermease
02

Mechanism of action

Inhibition or blockade of transport (preventing substrate movement); Modulation of transporter expression or localization; Utilization of transporter-mediated uptake for improved drug delivery; Competitive or non-competitive inhibition

03

Biological functions

Transport of ions, small molecules, and macromoleculesUptake of nutrientsRemoval of metabolites and toxinsSignal transductionRegulation of cellular concentrationsDrug uptake and effluxCell-cell recognitionCell homeostasis
04

Disease associations

Neurological diseaseCancerObesityKidney disease (e.g., cystinuria)Metabolic disordersMultidrug resistanceOther
05

Safety considerations

Drug interactions leading to altered pharmacokinetics (ADME)Off-target transport resulting in toxicityResistance mechanisms through efflux (decreasing drug efficacy)Genetic variants modulating transporter function and drug responseDifficulty in selectively targeting specific transporters due to family diversity
06

Interacting drugs

Gemcitabine

4 more in the full profile.

07

Biomarkers

Overexpression or mutation of specific transporter subtypes (e.g., ABCB1/MDR1 in multidrug resistance, SLC transporters in metabolic syndromes)Tissue-specific expression profilesTransporter activity assays

Beyond the preview

Go deeper on Membrane transporter protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Membrane transporter protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call